October 13, 2021Open Access

Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2‐mediated PI3K/Akt/mTOR signals

Key Points

Key points are not available for this paper at this time.

Abstract

Butyrate exerts protective effects on muscle atrophy induced by DN by enhancing intestinal barrier function and activating the FFA2 receptor-mediated PI3K/Akt/mTOR pathway.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Tang et al. (Wed,) studied this question.

synapsesocial.com/papers/69dc06a97dffaba91f374909 https://doi.org/https://doi.org/10.1111/bph.15693

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Diazepam and Its Disinfection Byproduct Promote the Early Development of Nervous System in Zebrafish Embryos2020 · 9 citations
2Succinylation-Alcian Blue Staining of Mucins on Polyvinylidene Difluoride Membranes2015 · 7 citations
3Metabolic endotoxemia and diabetes mellitus: A systematic review2016 · 331 citations
4Aging: A revisited theory based on free radicals generated by NOX family NADPH oxidases2006 · 191 citations
5Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR432009 · 3,210 citations

Demander à l'IA

Bookmark

View Full Paper